# Concentrix Corp: financial statements, quarterly

CNXC · Nasdaq · CIK 1803599 · [Industrials](/sectors/industrials.md) · fiscal year ends Nov 30

Pages: [Overview](/companies/cnxc.md) · [Financials](/companies/cnxc/financials.md) · [Filings](/companies/cnxc/filings.md) · [Insiders](/companies/cnxc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cnxc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,231 d](/filings/0001803599-26-000027.md) | [2,403](/filings/0001803599-25-000106.md) | [2,381](/filings/0001803599-25-000133.md) | [2,387](/filings/0001803599-25-000147.md) | [2,448 d](/filings/0001803599-26-000027.md) | [2,372](/filings/0001803599-26-000122.md) | [2,417](/filings/0001803599-26-000136.md) | [2,483](/filings/0001803599-26-000155.md) | [2,553 d](/filings/0001803599-26-000027.md) | [2,500](/filings/0001803599-26-000122.md) | [2,462](/filings/0001803599-26-000136.md) | [2,454](/filings/0001803599-26-000155.md) |
| Cost of revenue | $m | [1,408 d](/filings/0001803599-26-000027.md) | [1,546](/filings/0001803599-25-000106.md) | [1,523](/filings/0001803599-25-000133.md) | [1,523](/filings/0001803599-25-000147.md) | [1,577 d](/filings/0001803599-26-000027.md) | [1,516](/filings/0001803599-26-000122.md) | [1,569](/filings/0001803599-26-000136.md) | [1,628](/filings/0001803599-26-000155.md) | [1,677 d](/filings/0001803599-26-000027.md) | [1,651](/filings/0001803599-26-000122.md) | [1,639](/filings/0001803599-26-000136.md) | [1,605](/filings/0001803599-26-000155.md) |
| Gross profit | $m | [823 d](/filings/0001803599-26-000027.md) | [857](/filings/0001803599-25-000106.md) | [858](/filings/0001803599-25-000133.md) | [864](/filings/0001803599-25-000147.md) | [871 d](/filings/0001803599-26-000027.md) | [856](/filings/0001803599-26-000122.md) | [848](/filings/0001803599-26-000136.md) | [855](/filings/0001803599-26-000155.md) | [876 d](/filings/0001803599-26-000027.md) | [850](/filings/0001803599-26-000122.md) | [823](/filings/0001803599-26-000136.md) | [849](/filings/0001803599-26-000155.md) |
| Selling, general and administrative | $m | [642 d](/filings/0001803599-26-000027.md) | [708](/filings/0001803599-25-000106.md) | [707](/filings/0001803599-25-000133.md) | [711](/filings/0001803599-25-000147.md) | [726 d](/filings/0001803599-26-000027.md) | [687](/filings/0001803599-26-000122.md) | [700](/filings/0001803599-26-000136.md) | [708](/filings/0001803599-26-000155.md) | [731 d](/filings/0001803599-26-000027.md) | [731](/filings/0001803599-26-000122.md) | [728](/filings/0001803599-26-000136.md) | [709](/filings/0001803599-26-000155.md) |
| Operating income | $m | [180 d](/filings/0001803599-26-000027.md) | [148](/filings/0001803599-25-000106.md) | [150](/filings/0001803599-25-000133.md) | [153](/filings/0001803599-25-000147.md) | [145 d](/filings/0001803599-26-000027.md) | [169](/filings/0001803599-26-000122.md) | [148](/filings/0001803599-26-000136.md) | [147](/filings/0001803599-26-000155.md) | [(1,382) d](/filings/0001803599-26-000027.md) | [119](/filings/0001803599-26-000122.md) | [95.4](/filings/0001803599-26-000136.md) | [(910)](/filings/0001803599-26-000155.md) |
| Income tax | $m | [7.6 d](/filings/0001803599-26-000027.md) | [20.7](/filings/0001803599-25-000106.md) | [20.3](/filings/0001803599-25-000133.md) | [9.8](/filings/0001803599-25-000147.md) | [(2.7) d](/filings/0001803599-26-000027.md) | [30.5](/filings/0001803599-26-000122.md) | [9.6](/filings/0001803599-26-000136.md) | [23.3](/filings/0001803599-26-000155.md) | [33.2 d](/filings/0001803599-26-000027.md) | [7.1](/filings/0001803599-26-000122.md) | [14.2](/filings/0001803599-26-000136.md) | [8.3](/filings/0001803599-26-000155.md) |
| Net income | $m | [69.5 d](/filings/0001803599-26-000027.md) | [52.1](/filings/0001803599-25-000106.md) | [66.8](/filings/0001803599-25-000133.md) | [16.6](/filings/0001803599-25-000147.md) | [116 d](/filings/0001803599-26-000027.md) | [70.3](/filings/0001803599-26-000122.md) | [42.1](/filings/0001803599-26-000136.md) | [88.1](/filings/0001803599-26-000155.md) | [(1,479) d](/filings/0001803599-26-000027.md) | [21.6](/filings/0001803599-26-000122.md) | [55.3](/filings/0001803599-26-000136.md) | [(988)](/filings/0001803599-26-000155.md) |
| Diluted EPS | $ per share | not reported | [0.76](/filings/0001803599-25-000106.md) | [0.98](/filings/0001803599-25-000133.md) | [0.25](/filings/0001803599-25-000147.md) | not reported | [1.04](/filings/0001803599-26-000122.md) | [0.63](/filings/0001803599-26-000136.md) | [1.34](/filings/0001803599-26-000155.md) | not reported | [0.33](/filings/0001803599-26-000122.md) | [0.86](/filings/0001803599-26-000136.md) | [(16.24)](/filings/0001803599-26-000155.md) |
| Basic EPS | $ per share | not reported | [0.76](/filings/0001803599-25-000106.md) | [0.98](/filings/0001803599-25-000133.md) | [0.25](/filings/0001803599-25-000147.md) | not reported | [1.04](/filings/0001803599-26-000122.md) | [0.63](/filings/0001803599-26-000136.md) | [1.34](/filings/0001803599-26-000155.md) | not reported | [0.33](/filings/0001803599-26-000122.md) | [0.86](/filings/0001803599-26-000136.md) | [(16.24)](/filings/0001803599-26-000155.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0001803599-25-000022.md) | [0.2](/filings/0001803599-24-000108.md) | [0.2](/filings/0001803599-24-000130.md) | [0.2](/filings/0001803599-24-000156.md) | [0.2](/filings/0001803599-26-000027.md) | [0.3](/filings/0001803599-26-000122.md) | [0.3](/filings/0001803599-26-000136.md) | [0.4](/filings/0001803599-26-000155.md) | [0.3](/filings/0001803599-26-000155.md) | [0.2](/filings/0001803599-26-000122.md) | [0.3](/filings/0001803599-26-000136.md) | [0.2](/filings/0001803599-26-000155.md) |
| Current assets | $bn | [2.9](/filings/0001803599-25-000022.md) | [2.8](/filings/0001803599-24-000108.md) | [2.7](/filings/0001803599-24-000130.md) | [2.9](/filings/0001803599-24-000156.md) | [2.8](/filings/0001803599-26-000027.md) | [3.0](/filings/0001803599-25-000106.md) | [3.2](/filings/0001803599-25-000133.md) | [3.1](/filings/0001803599-25-000147.md) | [3.1](/filings/0001803599-26-000155.md) | [3.0](/filings/0001803599-26-000122.md) | [3.0](/filings/0001803599-26-000136.md) | [2.9](/filings/0001803599-26-000155.md) |
| Total assets | $bn | [12.5](/filings/0001803599-25-000022.md) | [12.2](/filings/0001803599-24-000108.md) | [12.1](/filings/0001803599-24-000130.md) | [12.2](/filings/0001803599-24-000156.md) | [12.0](/filings/0001803599-26-000027.md) | [11.9](/filings/0001803599-25-000106.md) | [12.4](/filings/0001803599-25-000133.md) | [12.4](/filings/0001803599-25-000147.md) | [10.8](/filings/0001803599-26-000155.md) | [10.7](/filings/0001803599-26-000122.md) | [10.5](/filings/0001803599-26-000136.md) | [9.3](/filings/0001803599-26-000155.md) |
| Current liabilities | $bn | [2.1](/filings/0001803599-25-000022.md) | [1.8](/filings/0001803599-24-000108.md) | [1.8](/filings/0001803599-24-000130.md) | [1.8](/filings/0001803599-24-000156.md) | [2.0](/filings/0001803599-26-000027.md) | [1.8](/filings/0001803599-25-000106.md) | [2.0](/filings/0001803599-25-000133.md) | [2.0](/filings/0001803599-25-000147.md) | [2.2](/filings/0001803599-26-000155.md) | [2.6](/filings/0001803599-26-000122.md) | [2.6](/filings/0001803599-26-000136.md) | [2.4](/filings/0001803599-26-000155.md) |
| Total liabilities | $bn | [8.3](/filings/0001803599-25-000022.md) | [8.1](/filings/0001803599-24-000108.md) | [8.0](/filings/0001803599-24-000130.md) | [8.0](/filings/0001803599-24-000156.md) | [8.0](/filings/0001803599-26-000027.md) | [7.9](/filings/0001803599-25-000106.md) | [8.1](/filings/0001803599-25-000133.md) | [8.1](/filings/0001803599-25-000147.md) | [8.0](/filings/0001803599-26-000155.md) | [7.9](/filings/0001803599-26-000122.md) | [7.8](/filings/0001803599-26-000136.md) | [7.5](/filings/0001803599-26-000155.md) |
| Long-term debt | $bn | [4.9](/filings/0001803599-25-000022.md) | [5.0](/filings/0001803599-24-000108.md) | [4.9](/filings/0001803599-24-000130.md) | [4.9](/filings/0001803599-24-000156.md) | [4.7](/filings/0001803599-26-000027.md) | [4.9](/filings/0001803599-25-000106.md) | [4.9](/filings/0001803599-25-000133.md) | [4.8](/filings/0001803599-25-000147.md) | [4.6](/filings/0001803599-26-000155.md) | [4.0](/filings/0001803599-26-000122.md) | [3.9](/filings/0001803599-26-000136.md) | [3.9](/filings/0001803599-26-000155.md) |
| Current portion of debt | $bn | [0.0](/filings/0001803599-25-000022.md) | [0.0](/filings/0001803599-24-000108.md) | [0.0](/filings/0001803599-24-000130.md) | [0.0](/filings/0001803599-24-000156.md) | [0.0](/filings/0001803599-26-000027.md) | [0.0](/filings/0001803599-25-000106.md) | [0.0](/filings/0001803599-25-000133.md) | [0.0](/filings/0001803599-25-000147.md) | [0.1](/filings/0001803599-26-000155.md) | [0.8](/filings/0001803599-26-000122.md) | [0.7](/filings/0001803599-26-000136.md) | [0.5](/filings/0001803599-26-000155.md) |
| Shareholders' equity | $bn | [4.1](/filings/0001803599-26-000027.md) | [4.1](/filings/0001803599-25-000133.md) | [4.1](/filings/0001803599-25-000147.md) | [4.2](/filings/0001803599-25-000147.md) | [4.0](/filings/0001803599-26-000155.md) | [4.0](/filings/0001803599-26-000136.md) | [4.3](/filings/0001803599-26-000155.md) | [4.3](/filings/0001803599-26-000155.md) | [2.7](/filings/0001803599-26-000155.md) | [2.8](/filings/0001803599-26-000136.md) | [2.7](/filings/0001803599-26-000155.md) | [1.8](/filings/0001803599-26-000155.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [229 d](/filings/0001803599-26-000027.md) | [(46.9)](/filings/0001803599-25-000106.md) | [238 d](/filings/0001803599-25-000133.md) | [192 d](/filings/0001803599-25-000147.md) | [284 d](/filings/0001803599-26-000027.md) | [1.4](/filings/0001803599-26-000122.md) | [237 d](/filings/0001803599-26-000136.md) | [225 d](/filings/0001803599-26-000155.md) | [344 d](/filings/0001803599-26-000027.md) | [(83.2)](/filings/0001803599-26-000122.md) | [258 d](/filings/0001803599-26-000136.md) | [268 d](/filings/0001803599-26-000155.md) |
| Capital expenditure | $m | [64.8 d](/filings/0001803599-26-000027.md) | [56.1](/filings/0001803599-25-000106.md) | [60.1 d](/filings/0001803599-25-000133.md) | [62.7 d](/filings/0001803599-25-000147.md) | [59.9 d](/filings/0001803599-26-000027.md) | [50.6](/filings/0001803599-26-000122.md) | [55.8 d](/filings/0001803599-26-000136.md) | [65.1 d](/filings/0001803599-26-000155.md) | [63.0 d](/filings/0001803599-26-000027.md) | [53.9](/filings/0001803599-26-000122.md) | [48.2 d](/filings/0001803599-26-000136.md) | [47.0 d](/filings/0001803599-26-000155.md) |
| Dividends paid | $m | [20.6 d](/filings/0001803599-26-000027.md) | [20.6](/filings/0001803599-25-000106.md) | [20.3 d](/filings/0001803599-25-000133.md) | [20.2 d](/filings/0001803599-25-000147.md) | [22.6 d](/filings/0001803599-26-000027.md) | [22.4](/filings/0001803599-26-000122.md) | [22.1 d](/filings/0001803599-26-000136.md) | [21.9 d](/filings/0001803599-26-000155.md) | [23.2 d](/filings/0001803599-26-000027.md) | [23.1](/filings/0001803599-26-000122.md) | [23.1 d](/filings/0001803599-26-000136.md) | [23.0 d](/filings/0001803599-26-000155.md) |
| Share repurchases | $m | [22.0 d](/filings/0001803599-26-000027.md) | [21.7](/filings/0001803599-25-000106.md) | [40.6 d](/filings/0001803599-25-000133.md) | [39.3 d](/filings/0001803599-25-000147.md) | [34.5 d](/filings/0001803599-26-000027.md) | [25.8](/filings/0001803599-26-000122.md) | [45.3 d](/filings/0001803599-26-000136.md) | [41.6 d](/filings/0001803599-26-000155.md) | [55.9 d](/filings/0001803599-26-000027.md) | [43.2](/filings/0001803599-26-000122.md) | [0.0 d](/filings/0001803599-26-000136.md) | [0.0 d](/filings/0001803599-26-000155.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-02-28) | Q2 FY2023 (2023-05-31) | Q3 FY2023 (2023-08-31) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [51.5](/filings/0001803599-24-000108.md) | [51.4](/filings/0001803599-24-000130.md) | [51.2](/filings/0001803599-24-000156.md) | [65.8](/filings/0001803599-25-000106.md) | [65.3](/filings/0001803599-25-000133.md) | [64.7](/filings/0001803599-25-000147.md) | [64.1](/filings/0001803599-26-000122.md) | [63.4](/filings/0001803599-26-000136.md) | [62.7](/filings/0001803599-26-000155.md) | [61.3](/filings/0001803599-26-000122.md) | [60.9](/filings/0001803599-26-000136.md) | [60.9](/filings/0001803599-26-000155.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 61,105,440 at 2026-09-30, from the cover of the [10-Q filed 2026-10-07](/filings/0001803599-26-000155.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.